From: Serositis as an indicator of poor prognosis in pediatric systemic lupus erythematosus
 | cSLE with early-onset serositis (N = 19, 50%) | cSLE with late-onset serositis (N = 19, 50%) | P-value |
---|---|---|---|
Female: Male, n (%) | 16:3 (84.21%) | 17:2 (89.47%) | 1.000 |
Age at diagnosis of SLE, mean ± SD, years | 12.87 ± 3.59 | 12.17 ± 2.54 | 0.507 |
Follow-up duration, mean ± SD, years | 4.33 ± 4.99 | 9.70 ± 5.73 | 0.004 |
Modified SLEDAI-2 K, mean ± SD | 15.52 ± 5.18 | 13.57 ± 4.58 | 0.240 |
Lupus nephritis, n (%) | 13 (68.42%) | 18 (94.73%) | 0.094 |
End-stage renal disease, n (%) | 4 (21.05%) | 14 (73.68%) | 0.003 |
Mortality, n (%) | 4 (21.05%) | 11 (57.89%) | 0.046 |
Age at death, mean ± SD, years | 14.25 ± 2.46 | 18.04 ± 4.80 | 0.183 |